Next Article in Journal
Applicability of Traditional In Vitro Toxicity Tests for Assessing Adverse Effects of Monoclonal Antibodies: A Case Study of Rituximab and Trastuzumab
Next Article in Special Issue
Relative Contribution of Framework and CDR Regions in Antibody Variable Domains to Multimerisation of Fv- and scFv-Containing Bispecific Antibodies
Previous Article in Journal / Special Issue
Engineering IgG-Like Bispecific Antibodies—An Overview
 
 
Article

Article Versions Notes

Antibodies 2018, 7(3), 29; https://doi.org/10.3390/antib7030029
Action Date Notes Link
article xml file uploaded 10 August 2018 16:15 CEST Original file -
article pdf uploaded. 10 August 2018 16:15 CEST Version of Record https://www.mdpi.com/2073-4468/7/3/29/pdf-vor
article pdf uploaded. 10 August 2018 16:16 CEST Updated version of record https://www.mdpi.com/2073-4468/7/3/29/pdf-vor
article xml file uploaded 11 August 2018 09:19 CEST Update -
article xml uploaded. 11 August 2018 09:19 CEST Update https://www.mdpi.com/2073-4468/7/3/29/xml
article pdf uploaded. 11 August 2018 09:19 CEST Updated version of record https://www.mdpi.com/2073-4468/7/3/29/pdf
article html file updated 11 August 2018 09:20 CEST Original file -
article html file updated 22 September 2018 12:57 CEST Update -
article html file updated 31 March 2019 07:17 CEST Update -
article html file updated 15 April 2019 13:00 CEST Update -
article html file updated 29 April 2019 17:42 CEST Update -
article html file updated 6 October 2019 13:55 CEST Update -
article html file updated 10 February 2020 05:30 CET Update -
article html file updated 17 July 2022 00:45 CEST Update https://www.mdpi.com/2073-4468/7/3/29/html
Back to TopTop